logo
ProjectEnded

MetabERN 3 years plan

One of 10,000+ projects Taiyo tracks in Italy.

Source: EU Funding & Tenders Portal

MetabERN is the first pan-European metabolic network that aims to facilitate access to the best available care for patients with rare inherited metabolic diseases (IMDs). MetabERN represents today 69 founding Healthcare Providers (HCPs) from 18 EU Member States and 44 patient organisations (POs), and is endorsed by the Society for the Inborn Errors of Metabolism (SSIEM). In line with the objectiv

Status
Closed
Sector
Government
Location
Italy
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about MetabERN 3 years plan

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “MetabERN 3 years plan” is an infrastructure initiative in the Government sector, located in Italy. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Sponsoring Agency

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

MetabERN is the first pan-European metabolic network that aims to facilitate access to the best available care for patients with rare inherited metabolic diseases (IMDs). MetabERN represents today 69 founding Healthcare Providers (HCPs) from 18 EU Member States and 44 patient organisations (POs), and is endorsed by the Society for the Inborn Errors of Metabolism (SSIEM). In line with the objectives and services defined in the proposal for a Framework Partnership Agreement, MetabERN aims to continue optimising the programmes centred on high-quality patient care. In particular MetabERN will: 1) strengthen the collaboration between participating HCPs and patients; 2) increase awareness of hereditary metabolic diseases in relevant communities; 3) develop dedicated educational and training programmes to address the identified HCPs’ and patients’ needs; 4) develop guidelines and clinical pathway recommendations on IMDs; 5) optimise the use of the Clinical Patient Management System (CPMS) and other service platforms to advance cross border collaboration for optimal diagnosis and treatment of rare IMDs; 6) analyse the state-of-play in IMD diagnosis and care; 7) ensure systematic involvement of patient representatives in MetabERN activities, and 8) put in place an efficient monitoring system for quality assurance of the overall execution of the three-year plan. To demonstrate the crucial importance of patient involvement and participation, a dedicated work package has been included in the work plan.

Location

Country

Italy

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Government

Article published date

2026-02-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project